Cargando…
Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer
Microsatellite instability (MSI) and tumor mutational burden (TMB) are indicators of the tumor mutational load, which can lead to immune cell recruitment. By contrast, the number of tumor-infiltrating T cells (TITs) is indicative of the host immune response to tumor cells. The present study evaluate...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533364/ https://www.ncbi.nlm.nih.gov/pubmed/36276483 http://dx.doi.org/10.3892/ol.2022.13516 |
_version_ | 1784802328344264704 |
---|---|
author | Shigaki, Takahiro Fujiyoshi, Kenji Sudo, Tomoya Kawahara, Akihiro Nakane, Hiroyuki Yomoda, Takato Nagasu, Sachiko Kinugasa, Tetsushi Akiba, Jun Fujita, Fumihiko Akagi, Yoshito |
author_facet | Shigaki, Takahiro Fujiyoshi, Kenji Sudo, Tomoya Kawahara, Akihiro Nakane, Hiroyuki Yomoda, Takato Nagasu, Sachiko Kinugasa, Tetsushi Akiba, Jun Fujita, Fumihiko Akagi, Yoshito |
author_sort | Shigaki, Takahiro |
collection | PubMed |
description | Microsatellite instability (MSI) and tumor mutational burden (TMB) are indicators of the tumor mutational load, which can lead to immune cell recruitment. By contrast, the number of tumor-infiltrating T cells (TITs) is indicative of the host immune response to tumor cells. The present study evaluated if the expression of mismatch repair (MMR) proteins can be used as a precise tool to assess immunogenicity in the tumor microenvironment. A total of 73 colorectal cancer cases were enrolled in the present study. MMR protein expression was assessed using four-antibodies immunohistochemistry (IHC) targeting MLH1, MSH2, MSH6 and PMS2. TIT was assessed through IHC by counting CD3(+) and CD8(+) cells in tumor. The enrolled cases were classified into four groups according to MMR and TIT status i) Mismatch repair-proficient (pMMR) and a high number of TITs (pMMR/TIT-H); ii) pMMR and a low number of TITs (pMMR/TIT-L); iii) mismatch repair-deficient (dMMR) and TIT-H (dMMR/TIT-H); and iv) dMMR/TIT-L]. The present study evaluated the clinicopathological characteristics of the four groups, in addition to the difference of TMB. TMB analysis was counted the number of the somatic mutations through multi-genes panel using next-generation sequencing. Clinicopathological characteristics, including age, sex, pathological depth of invasion and lymph node metastasis, were not found to be statistically different between dMMR/TIT-H and dMMR/TIT-L groups. Tumors among pMMR/TIT-H group were associated with poorly differentiation compared with those in pMMR/TIT-L group (P=0.025). The median TMB among the dMMR/TIT-H group was the highest in four groups but the median TMB was <10 muts/Mb in dMMR/TIT-L, pMMR/TIT-H and pMMR/TIT-L groups, respectively. However, one tumor in the pMMR/TIT-H group showed high TMB. The present findings suggest that assessing MMR status alone may not be sufficient to precisely evaluate the antitumor immune response in the tumor microenvironment. |
format | Online Article Text |
id | pubmed-9533364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-95333642022-10-20 Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer Shigaki, Takahiro Fujiyoshi, Kenji Sudo, Tomoya Kawahara, Akihiro Nakane, Hiroyuki Yomoda, Takato Nagasu, Sachiko Kinugasa, Tetsushi Akiba, Jun Fujita, Fumihiko Akagi, Yoshito Oncol Lett Articles Microsatellite instability (MSI) and tumor mutational burden (TMB) are indicators of the tumor mutational load, which can lead to immune cell recruitment. By contrast, the number of tumor-infiltrating T cells (TITs) is indicative of the host immune response to tumor cells. The present study evaluated if the expression of mismatch repair (MMR) proteins can be used as a precise tool to assess immunogenicity in the tumor microenvironment. A total of 73 colorectal cancer cases were enrolled in the present study. MMR protein expression was assessed using four-antibodies immunohistochemistry (IHC) targeting MLH1, MSH2, MSH6 and PMS2. TIT was assessed through IHC by counting CD3(+) and CD8(+) cells in tumor. The enrolled cases were classified into four groups according to MMR and TIT status i) Mismatch repair-proficient (pMMR) and a high number of TITs (pMMR/TIT-H); ii) pMMR and a low number of TITs (pMMR/TIT-L); iii) mismatch repair-deficient (dMMR) and TIT-H (dMMR/TIT-H); and iv) dMMR/TIT-L]. The present study evaluated the clinicopathological characteristics of the four groups, in addition to the difference of TMB. TMB analysis was counted the number of the somatic mutations through multi-genes panel using next-generation sequencing. Clinicopathological characteristics, including age, sex, pathological depth of invasion and lymph node metastasis, were not found to be statistically different between dMMR/TIT-H and dMMR/TIT-L groups. Tumors among pMMR/TIT-H group were associated with poorly differentiation compared with those in pMMR/TIT-L group (P=0.025). The median TMB among the dMMR/TIT-H group was the highest in four groups but the median TMB was <10 muts/Mb in dMMR/TIT-L, pMMR/TIT-H and pMMR/TIT-L groups, respectively. However, one tumor in the pMMR/TIT-H group showed high TMB. The present findings suggest that assessing MMR status alone may not be sufficient to precisely evaluate the antitumor immune response in the tumor microenvironment. D.A. Spandidos 2022-09-21 /pmc/articles/PMC9533364/ /pubmed/36276483 http://dx.doi.org/10.3892/ol.2022.13516 Text en Copyright: © Shigaki et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Shigaki, Takahiro Fujiyoshi, Kenji Sudo, Tomoya Kawahara, Akihiro Nakane, Hiroyuki Yomoda, Takato Nagasu, Sachiko Kinugasa, Tetsushi Akiba, Jun Fujita, Fumihiko Akagi, Yoshito Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title | Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title_full | Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title_fullStr | Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title_full_unstemmed | Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title_short | Mismatch repair proteins expression and tumor-infiltrating T-cells in colorectal cancer |
title_sort | mismatch repair proteins expression and tumor-infiltrating t-cells in colorectal cancer |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533364/ https://www.ncbi.nlm.nih.gov/pubmed/36276483 http://dx.doi.org/10.3892/ol.2022.13516 |
work_keys_str_mv | AT shigakitakahiro mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT fujiyoshikenji mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT sudotomoya mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT kawaharaakihiro mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT nakanehiroyuki mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT yomodatakato mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT nagasusachiko mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT kinugasatetsushi mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT akibajun mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT fujitafumihiko mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer AT akagiyoshito mismatchrepairproteinsexpressionandtumorinfiltratingtcellsincolorectalcancer |